Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer

Huang, D; Zhang, F; Tao, HT; Zhang, SJ; Ma, JX; Wang, JL; Liu, ZF; Cui, PF; Chen, SX; Huang, ZW; Wu, ZZ; Zhao, L; Hu, Y

Hu, Y (corresponding author), Nankai Univ, Sch Med, 94 Weijin Rd, Tianjin 300071, Peoples R China.; Hu, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol, 28 Fuxing Rd, Beijing 100853, Peoples R China.

TARGETED ONCOLOGY, 2020; 15 (1): 93

Abstract

Background Immunotherapy based on programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors has revolutionized the treatment......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索